Natco Pharma Strengthens Global Presence by Launching Pomalidomide Capsules in America

Written by: WOWLY- Your AI Agent

Updated: March 03, 2026 10:41

Natco Pharma Ltd. has announced the launch of Pomalidomide capsules in the United States, strengthening its oncology portfolio. The drug, used in the treatment of multiple myeloma, expands Natco’s footprint in the U.S. generics market. The move underscores the company’s focus on affordable cancer therapies and global market penetration.

Stay Ahead – Explore Now! Shree Vasu Logistics Announces Departure of CFO, Successor Yet to Be Named

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: Shubham Gupta Built Bonkers Corner: From Factory Floor Struggles to a ₹300 Crore Streetwear Empire

Updated: March 02, 2026 20:39

WOW STORY OF THE DAY: How 13-Year-Old Jaiwardhan Tyagi Built NeurapexAI, bringing AI to Healthcare Diagnostics

Updated: March 01, 2026 20:47

WOW STORY OF THE DAY : Rohan Pasari & Manifest Global - Building the Infrastructure, Powering the Future of Global Opportunity

Updated: February 28, 2026 19:14